Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
32984
CAS Number:
166603-46-9
Human CMV Assemblin Protease Inhibitor
Synonym(s):
H-Arg-Gly-Val-Val-Asn-Ala-psi(CH2NH)Ser-Ser-Arg-Leu-Ala-OH
Documents
$778.87 /1MG
Pack Size Availability Price
Request Bulk Quote
Product Information

The Human CMV Assemblin Protease Inhibitor is a specialized compound designed to target and inhibit the activity of the cytomegalovirus (CMV) protease, a crucial enzyme involved in the viral replication process. This inhibitor is particularly relevant in the field of virology and pharmaceutical research, as it holds potential for the development of antiviral therapies aimed at treating CMV infections, which can lead to severe complications in immunocompromised patients. Its unique mechanism of action allows for selective inhibition, minimizing off-target effects and enhancing therapeutic efficacy.

Researchers and industry professionals can leverage this compound in drug discovery and development, particularly in formulating treatments for CMV-related diseases. Its specificity for the CMV protease positions it as a promising candidate for further investigation in clinical applications, potentially leading to improved patient outcomes. The compound's ability to disrupt viral replication pathways makes it an invaluable tool in the ongoing fight against viral infections, offering hope for innovative therapeutic strategies.

Synonyms
H-Arg-Gly-Val-Val-Asn-Ala-psi(CH2NH)Ser-Ser-Arg-Leu-Ala-OH
CAS Number
166603-46-9
Molecular Formula
C46H86N18O14
Molecular Weight
1115.3
MDL Number
MFCD31692280
Conditions
Store at ≤ -10 °C
General Information
Synonyms
H-Arg-Gly-Val-Val-Asn-Ala-psi(CH2NH)Ser-Ser-Arg-Leu-Ala-OH
CAS Number
166603-46-9
Molecular Formula
C46H86N18O14
Molecular Weight
1115.3
MDL Number
MFCD31692280
Conditions
Store at ≤ -10 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Human CMV Assemblin Protease Inhibitor is widely utilized in research focused on:

  • Antiviral Drug Development: This compound plays a crucial role in the development of antiviral therapies targeting cytomegalovirus (CMV), which is particularly important for immunocompromised patients, such as organ transplant recipients.
  • Research on Viral Proteases: It is used in studies investigating the mechanisms of viral proteases, aiding scientists in understanding how these enzymes function and how they can be inhibited to prevent viral replication.
  • Pharmaceutical Formulations: The compound is incorporated into drug formulations aimed at enhancing efficacy against CMV, providing a targeted approach that minimizes side effects compared to broad-spectrum antivirals.
  • Biochemical Assays: Researchers utilize this inhibitor in biochemical assays to screen for new antiviral compounds, helping to identify potential candidates for future drug development.
  • Clinical Research: It is involved in clinical studies assessing the safety and effectiveness of new treatments for CMV infections, contributing to advancements in patient care and treatment protocols.

Citations